Viewing Study NCT02797704


Ignite Creation Date: 2025-12-24 @ 9:07 PM
Ignite Modification Date: 2026-01-25 @ 3:20 AM
Study NCT ID: NCT02797704
Status: TERMINATED
Last Update Posted: 2019-09-16
First Post: 2016-05-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Subconjunctival Aflibercept (EYLEA®) for the Treatment of Corneal Neovascularization
Sponsor: Rabin Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module